Queen Silvia of Sweden becomes ADI Ambassador

06 December 2018 – Her Majesty Queen Silvia of Sweden has become an Honorary  Ambassador of Alzheimer’s Disease International (ADI), in recognition of her  personal commitment to work surrounding elderly and end of life care, and specifically dementia.

Queen Silvia has a long-standing association with, and support of dementia, in 1996  having initiated a dementia care training programme for hospital personnel in Sweden by the foundation Stiftelsen Silviahemmet.

Queen Silvia said: “I am honoured to act as an Ambassador for Alzheimer’s Disease International, an organisation which addresses many issues which are important to me. Dementia will continue to affect populations globally, especially rapidly ageing populations such as Sweden. In the continued absence of a disease modifying treatment, more research must be pioneered into risk reduction and care improvements, including world leading risk-reduction research.”

Chief Executive of ADI, Paola Barbarino, said: “We are delighted to have the support of Queen Silvia, whose long-standing dedication to the field of dementia and ageing is well known. Having such patronage at the forefront of our work is crucial for raising awareness and galvanising the influence needed to take action on dementia globally.”

Krister Westerlund, Chairman of Alzheimer Sverige, said: "Alzheimer Sverige, proud members of ADI since 1986, are today happy to acknowledge that HRH Queen Silvia is committing her full attention to help persons with Alzheimer's disease and other dementias. As Chairman of Alzheimer Sverige, I have had the opportunity to involve Queen Silvia in our World Alzheimer’s Month activities. Her work, as well as that of the Swedish Court, has been greatly appreciated by our members, and I am therefore extremely happy to see that Queen Silvia’s efforts will receive global recognition.”

Luis Guillermo Solís Rivera, President of Costa Rica and Queen Sofia of Spain are also Honorary Ambassadors of ADI.

Dementia is one of the most significant global health and social crises in the 21st century, but collaborative, global action and funding are sorely needed to address the impact of dementia.

Where next?